Basic Neurosciences · Paper A
Vascular dementia: diagnosis, course and management
Vascular dementia is what happens when the everyday causes of heart attacks and strokes — high blood pressure, diabetes, smoking, atrial fibrillation — do their damage to the brain's blood supply instead of the heart's. It is not a separate disease with its own private risk factors; it is ordinary vascular disease reaching the brain, which is exactly why treating it means treating blood pressure and cholesterol, not reaching for a dementia drug first.
⚠️ Assuming ALL vascular dementia shows a classic stepwise decline — mixed dementia is common and many real-world cases show a smoother course, especially subcortical/Binswanger's disease.
⚠️ Assuming CADASIL patients must have traditional vascular risk factors — the classic exam trap is a young patient with strokes and NO hypertension, diabetes or smoking history, which still points to a genetic vascular dementia.
⚠️ Assuming cholinesterase inhibitors and memantine work as well in vascular dementia as in Alzheimer's — the evidence in PURE vascular dementia is weak and inconsistent, unlike their proven efficacy in Alzheimer's.
⚠️ Treating any elderly patient with a stroke history and memory loss as automatically 'vascular dementia' without checking the course — a gradual, memory-led decline in that same patient may actually be coexisting Alzheimer's pathology (mixed dementia) rather than pure vascular disease.
⚠️ Forgetting that management is about the vascular risk factors themselves (antihypertensives, statins, antiplatelets, smoking cessation) rather than reaching first for a dementia drug.
Picture two patients on the same ward round, both eighty, both confused. The first has been fading slowly for three years — a little worse each visit, never dramatically. The second was sharp until eighteen months ago, then dropped suddenly after a stroke, held steady for a year, then dropped again after a second stroke last month. Same age, same word on the chart — 'dementia' — but two different diseases with two different treatments. The second patient's disease is written into its own name: vascular dementia, cognitive decline caused by damaged blood vessels rather than a slow build-up of abnormal protein. This page builds that idea from zero.
Vascular dementia (VaD) is cognitive decline caused by damage to the brain's blood supply, and it is the second most common cause of dementia after Alzheimer's disease. Its risk factors are not special to the brain at all — they are exactly the same list that causes heart attacks, strokes and poor circulation in the legs: hypertension (high blood pressure, the single most important factor, especially from midlife onward), diabetes, hyperlipidaemia (raised blood fats), smoking, atrial fibrillation (an irregular heart rhythm that can throw off clots) and a prior stroke or TIA (transient ischaemic attack, a mini-stroke that fully resolves). Whatever damages blood vessels elsewhere in the body can, given enough of it, damage the vessels supplying the brain too.
The trap almost everyone falls into: assuming vascular dementia always looks the same. It does not. The textbook picture is a STEPWISE course — a sudden drop in function right after a stroke, then a plateau, then another drop after the next stroke — contrasted with Alzheimer's smooth, gradual decline. That contrast is real and highly testable. But it is not universal. Diffuse small-vessel disease can produce a smoother, more gradual-looking decline, and many older patients carry both vascular damage and Alzheimer's pathology together (mixed dementia), blurring the clean pattern an exam question wants. And one genuine exception inverts the risk-factor rule entirely: CADASIL, a rare genetic small-vessel disease, causes vascular dementia in young patients with none of the usual risk factors at all.
Think of the brain's blood supply as a plumbing network for a whole city. Every artery and vein, right down to the smallest capillaries, exists to move blood — and with it, oxygen and glucose — to living tissue. Brain tissue is exceptionally hungry for both and survives only minutes without them. Hypertension is like running every pipe in the city at far higher pressure than it was built for: over years, the pipe walls thicken and stiffen, and eventually some burst or block. Diabetes damages the smallest pipes directly, from the inside. Smoking and high cholesterol both accelerate the same wall damage. Atrial fibrillation is a different kind of problem — the heart's chambers quiver instead of beating properly, letting blood pool and clot, and one of those clots can suddenly block a brain artery outright, causing a stroke.
Whatever the mechanism, the end result is the same: a patch of brain tissue loses its blood supply and the cells there die. What happens to cognition next depends entirely on HOW that damage accumulates. A few large blockages produce sudden drops — the stepwise pattern. Many tiny vessels narrowing together, more gradually, over years, produce a smoother decline instead. Both are vascular dementia; they simply reflect different plumbing failures within the same underlying disease.
Vascular dementia is not one uniform disease, and recognising its subtypes is largely a matter of recognising WHERE and HOW the plumbing failed.
Multi-infarct dementia is the most straightforward: many separate strokes add up over time until the cumulative loss produces dementia — the classic stepwise course, one drop per stroke. Strategic infarct dementia shows that location matters more than size: a single small infarct in a critical hub, such as the or the angular gyrus, can cause a disproportionately severe syndrome, because that one small area is a bottleneck much larger brain circuits depend on.
Subcortical vascular dementia, also called Binswanger's disease, is diffuse rather than discrete: chronic small-vessel disease, almost always from decades of poorly controlled hypertension, damages the (the brain's internal wiring, the long connecting fibres between regions) broadly rather than in isolated patches. The result is prominent executive dysfunction (difficulty planning, organising and adapting to change), slowing and a shuffling gait, often with memory relatively spared early on — a very different flavour from the memory-first picture of Alzheimer's.
For example, imagine a 35-year-old woman with a lifelong history of migraine with aura who has just had her second stroke, has never smoked, has normal blood pressure and normal blood sugar, and whose mother had an identical illness in her forties. Every instinct built from the ordinary risk-factor list says 'not vascular' — and every instinct would be wrong. CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is caused by a mutation in the NOTCH3 gene, which weakens small vessel walls directly, through inheritance rather than lifestyle. It is the exam's deliberate reminder that 'vascular' describes a mechanism, not a checklist of risk factors that must always be ticked.
Several other conditions can resemble vascular dementia closely enough to catch out a rushed reading of the vignette.
| Looks similar | How to tell it apart |
|---|---|
| Alzheimer's disease | Gradual, memory-led decline with no stroke history; imaging shows hippocampal atrophy rather than infarcts or disease. |
| Dementia with Lewy bodies | Fluctuating cognition WITH vivid visual and spontaneous parkinsonism, not tied to discrete vascular events. |
| Depression (pseudodementia) | Shorter timescale tied to a mood trigger, effortful 'do not know' answers, and improvement once the depression is treated. |
| Delirium | Acute, hours-to-days fluctuation in attention with an identifiable precipitant, not a chronic vascular course. |
| Normal pressure hydrocephalus | Gait disturbance and incontinence dominate, but imaging shows ventriculomegaly out of proportion to atrophy, not white matter disease. |
None of these differentials is exotic — each is common, and an examiner expects it told apart from vascular dementia by the course and the imaging pattern, not by age alone.
There is no single blood test for vascular dementia; the diagnosis rests on the clinical history (a stepwise or vascular-pattern course, vascular risk factors, sometimes focal neurological signs), cognitive screening (tools such as the MMSE or MoCA) and structural imaging (CT, or preferably MRI, showing infarcts, strategic lesions or change). The Hachinski Ischaemic Score is the classic bedside screening tool for weighing vascular features — abrupt onset, stepwise deterioration, fluctuating course, history of stroke, focal signs — against a more Alzheimer's-like picture, though imaging and the overall clinical picture carry more weight in practice. A vascular risk factor screen (blood pressure, glucose, lipids, cardiac rhythm) completes the work-up, since it identifies what needs treating.
Management follows directly from the cause: since vascular dementia is vascular disease reaching the brain, treatment targets the same vascular risk factors that caused it, following NICE guideline NG97 (Dementia: assessment, management and support) — blood pressure control, statin therapy, antiplatelet or anticoagulant treatment where indicated, smoking cessation and good diabetes control. This is the biggest actionable difference from Alzheimer's disease management: the first-line approach is secondary prevention, not a cognitive enhancer. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine have proven efficacy in Alzheimer's disease but only weak, inconsistent evidence in pure vascular dementia; a clinician may still prescribe them off-label, or when mixed dementia is suspected, but they are not the default first prescription that vascular risk factor treatment is.
Whenever a vignette pairs a stepwise course with the standard vascular risk factors, the answer is vascular dementia — but whenever it pairs strokes and dementia in a YOUNG patient with migraine and NO risk factors, the answer is CADASIL, not 'not vascular'. Before moving on, could you explain to a colleague why a 35-year-old with no hypertension and no diabetes can still have a genetically caused vascular dementia?
Vascular dementia is ordinary vascular disease reaching the brain — usually stepwise, always risk-factor-driven except in CADASIL, and treated by controlling those risk factors rather than by a dementia drug.